Pharmaceuticals, Biotechnology and Life Sciences
Clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, Adverum Biotechnologies on Tuesday announced the opening of its new corporate headquarters at one of the largest biotechnology research complexes in the San Francisco Bay Area.
BOSTON & SYDNEY–(BUSINESS WIRE)–GI Dynamics® Inc. (ASX:GID), a medical device company that is developing EndoBarrier® for patients with type 2…
WALTHAM, Mass.–(BUSINESS WIRE)–ImmunoGen, Inc., (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of…
LEXINGTON, Mass.–(BUSINESS WIRE)–$CNCE #CNCE—Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the U.S. Court of Appeals for the Federal Circuit…
The WHO disease classification will now include a disease called CDKL5 Deficiency Disorder. CDKL5 Deficiency Disorder diagnostic code will be…
ROCKVILLE, Md.–(BUSINESS WIRE)–OncoImmune, Inc. announced today that clinical data from its Phase IIa clinical trial of CD24Fc are being presented…
ROCKVILLE, Md.–(BUSINESS WIRE)–OncoImmune, Inc. announced today that clinical data from its Phase IIa clinical trial of CD24Fc are being presented…
SEATTLE–(BUSINESS WIRE)–#biotech—NanoSurface Biomedical, a leading provider of biomimetic cell-based assay products and services, announced today the launch of the 384-well…
SEATTLE–(BUSINESS WIRE)–#biotech—NanoSurface Biomedical, a leading provider of biomimetic cell-based assay products and services, announced today the launch of the 384-well…
Provides $9.3 Million in Additional Value Compared with China Grand Takeover and Gives Stockholders the Opportunity to Receive a Cash…